Remove Chemotherapy Remove Compounding Remove Definition
article thumbnail

Ipsen to buy biopharmaceutical company Epizyme for $247m

Pharmaceutical Technology

Ipsen has signed a definitive merger agreement to acquire all the outstanding shares of commercial-stage biopharmaceutical company Epizyme, for an initial total consideration of $247m. The transaction is focused on Epizyme’s lead asset, Tazverik (tazemetostat), a chemotherapy-free EZH2 a inhibitor. for each share. for each share.

article thumbnail

2020 review – Pharma’s progress outside of COVID-19

pharmaphorum

While Trodelvy is already conditionally approved in the US, the data showing the drug improved overall survival compared with chemotherapy could be enough for it to clinch a permanent licence in the US. months in patients treated with chemotherapy. In the 500 patient trial, patients treated with Trodelvy lived for a median of 12.1

FDA 96
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Joint Basis for FDA/HHS Marijuana Rescheduling Recommendation Unveiled

The FDA Law Blog

within the CSA’s definition of “marihuana” or “marijuana” based on FDA’s eight factor analysis. whether growing or not; its seeds; resin extracted from any part; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds or resin. chemotherapy-induced), pain, and post-traumatic stress disorder.

FDA 69
article thumbnail

Fluoride And Your Thyroid

The Thyroid Pharmacist

The fluorine anion (negatively charged ion), or any of the compounds containing the anion, are termed fluorides. Those are definitely a lot of issues those of us with Hashimoto’s want to avoid, along with everyone else. In pure form, it is a highly-toxic, yellowish-green gas.

article thumbnail

Selenium: The Nutrient That Can Reduce Thyroid Antibodies by 40%

The Thyroid Pharmacist

As of 2018, there have been at least two active studies underway to gain more definitive results, the GRASS (Graves’ Disease Selenium Supplementation) and the CATALYST (The Chronic Autoimmune Thyroiditis Quality of Life Selenium Trial). Institute of Medicine (US) Panel on Dietary Antioxidants and Related Compounds. 2017;2017:2549491.

Dosage 59